Magnetic Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing.
BiotechDigital HealthMedical DevicesLos Angeles, US
Stella Sarraf(Executive Officer, Director)James Khodabakhsh(Director)Mervyn Turner(Director)Faith Charles(Director)
Board seatChristine Aylward· per SEC Form D · $6M raise · filed Dec 2023
New Haven, US
Stephen Klapper(Executive Officer)Brandon Rice(Executive Officer)Aryeh Caroline(Executive Officer, Director)
BoardUmut Eser(Executive Officer)Joel Dudley(Director)in
Board seatChristine Aylward· per SEC Form D · $11.4M raise · filed Dec 2023
Co-investorsInnovation Endeavors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.